A Randomized Case-Controlled Study of Recombinant Human Granulocyte Colony Stimulating Factor for the Treatment of Sepsis in Preterm Neutropenic Infants

Article English OPEN
Doğukan Aktaş; Bilge Demirel; Tuğba Gürsoy; Fahri Ovalı; (2015)
  • Publisher: Elsevier
  • Journal: Pediatrics and Neonatology,volume 56,issue 3,pages171-175 (issn: 1875-9572)
  • Related identifiers: doi: 10.1016/j.pedneo.2014.06.007
  • Subject: Pediatrics, Perinatology, and Child Health | RJ1-570 | neutropenia, sepsis | Pediatrics | preterm | colony stimulating factor

To investigate the efficacy and safety of recombinant human granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor (rhG-CSF) to treat sepsis in neutropenic preterm infants. Methods: Fifty-six neutropenic preterm infa... View more
Share - Bookmark